Adjuvants for allergy vaccines

References

• Noon L. Prophylactic inoculation against hay fever. Lancet 1911; 177:1572 - 3; http://dx.doi.org/10.1016/S0140-6736(00)78276-6
   Google Scholar
• Freeman J. Further observations on the treatment of hay fever by hypodermic inoculations of pollen vaccine. Lancet 1911; 178:814 - 7; http://dx.doi.org/10.1016/S0140-6736(01)40417-X
   Google Scholar
• Bousquet J, Lockey R, Malling HJ. Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper. J Allergy Clin Immunol 1998; 102:558 - 62; http://dx.doi.org/10.1016/S0091-6749(98)70271-4; PMID: 9802362
   PubMed Web of Science ®Google Scholar
• Akdis CA, Akdis M. Mechanisms of allergen-specific immunotherapy. J Allergy Clin Immunol 2011; 127:18 - 27, quiz 28-9; http://dx.doi.org/10.1016/j.jaci.2010.11.030; PMID: 21211639
   PubMed Web of Science ®Google Scholar
• Joint Task Force on Practice Parameters, American Academy of Allergy, Asthma and Immunology, American College of Allergy, Asthma and Immunology, Joint Council of Allergy, Asthma and Immunology. Allergen immunotherapy: a practice parameter second update. J Allergy Clin Immunol 2007; 120:Suppl S25 - 85; http://dx.doi.org/10.1016/j.jaci.2007.06.019; PMID: 17765078
   PubMed Web of Science ®Google Scholar
• Bousquet J, Van Cauwenberge P, Khaltaev N, Aria Workshop Group, World Health Organization. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001; 108:Suppl S147 - 334; http://dx.doi.org/10.1067/mai.2001.118891; PMID: 11707753
   PubMed Web of Science ®Google Scholar
• Wilcock LK, Francis JN, Durham SR. Aluminium hydroxide down-regulates T helper 2 responses by allergen-stimulated human peripheral blood mononuclear cells. Clin Exp Allergy 2004; 34:1373 - 8; http://dx.doi.org/10.1111/j.1365-2222.2004.02052.x; PMID: 15347369
   PubMed Web of Science ®Google Scholar
• Mascarell L, Van Overtvelt L, Moingeon P. Novel ways for immune intervention in immunotherapy: mucosal allergy vaccines. Immunol Allergy Clin North Am 2006; 26:283 - 306, vii-viii; http://dx.doi.org/10.1016/j.iac.2006.02.009; PMID: 16701145
   PubMed Web of Science ®Google Scholar
• Canonica GW, Bousquet J, Casale T, Lockey RF, Baena-Cagnani CE, Pawankar R, et al. Sub-lingual immunotherapy: World Allergy Organization Position Paper 2009. Allergy 2009; 64:Suppl 91 1 - 59; http://dx.doi.org/10.1111/j.1398-9995.2009.02309.x; PMID: 20041860
   PubMed Web of Science ®Google Scholar
• Wilson DR, Torres LI, Durham SR. Sublingual immunotherapy for allergic rhinitis. Cochrane Database Syst Rev 2003; CD002893; PMID: 12804442
   PubMedGoogle Scholar
• Passalacqua G, Lombardi C, Troise C, Canonica GW. Sublingual immunotherapy: certainties, unmet needs and future directions. Eur Ann Allergy Clin Immunol 2009; 41:163 - 70; PMID: 20128229
   PubMedGoogle Scholar
• Moingeon P, Lombardi V, Saint-Lu N, Tourdot S, Bodo V, Mascarell L. Adjuvants and vector systems for allergy vaccines. Immunol Allergy Clin North Am 2011; 31:407 - 19, xii; http://dx.doi.org/10.1016/j.iac.2011.03.001; PMID: 21530828
   PubMed Web of Science ®Google Scholar
• Wheeler AW, Woroniecki SR. Immunological adjuvants in allergy vaccines: Past, present and future. Allergol Int 2001; 50:295 - 301; http://dx.doi.org/10.1046/j.1440-1592.2001.00230.x
   Google Scholar
• Valenta R, Niederberger V. Recombinant allergens for immunotherapy. J Allergy Clin Immunol 2007; 119:826 - 30; http://dx.doi.org/10.1016/j.jaci.2007.01.025; PMID: 17335886
   PubMed Web of Science ®Google Scholar
• Crameri R, Rhyner C. Novel vaccines and adjuvants for allergen-specific immunotherapy. Curr Opin Immunol 2006; 18:761 - 8; http://dx.doi.org/10.1016/j.coi.2006.09.001; PMID: 17010585
   PubMed Web of Science ®Google Scholar
• Vajdy M, Srivastava I, Polo J, Donnelly J, O’Hagan D, Singh M. Mucosal adjuvants and delivery systems for protein-, DNA- and RNA-based vaccines. Immunol Cell Biol 2004; 82:617 - 27; http://dx.doi.org/10.1111/j.1440-1711.2004.01288.x; PMID: 15550120
   PubMed Web of Science ®Google Scholar
• Chapman MD, Wünschmann S, Pomés A. Proteases as Th2 adjuvants. Curr Allergy Asthma Rep 2007; 7:363 - 7; http://dx.doi.org/10.1007/s11882-007-0055-6; PMID: 17697645
   PubMed Web of Science ®Google Scholar
• Trivedi B, Valerio C, Slater JE. Endotoxin content of standardized allergen vaccines. J Allergy Clin Immunol 2003; 111:777 - 83; http://dx.doi.org/10.1067/mai.2003.1338; PMID: 12704357
   PubMed Web of Science ®Google Scholar
• Till SJ, Francis JN, Nouri-Aria K, Durham SR. Mechanisms of immunotherapy. J Allergy Clin Immunol 2004; 113:1025 - 34, quiz 1035; http://dx.doi.org/10.1016/j.jaci.2004.03.024; PMID: 15208578
   PubMed Web of Science ®Google Scholar
• Moingeon P, Batard T, Fadel R, Frati F, Sieber J, Van Overtvelt L. Immune mechanisms of allergen-specific sublingual immunotherapy. Allergy 2006; 61:151 - 65; http://dx.doi.org/10.1111/j.1398-9995.2006.01002.x; PMID: 16409190
   PubMed Web of Science ®Google Scholar
• Francis JN, Till SJ, Durham SR. Induction of IL-10+CD4+CD25+ T cells by grass pollen immunotherapy. J Allergy Clin Immunol 2003; 111:1255 - 61; http://dx.doi.org/10.1067/mai.2003.1570; PMID: 12789226
   PubMed Web of Science ®Google Scholar
• Durham SR, Ying S, Varney VA, Jacobson MR, Sudderick RM, Mackay IS, et al. Grass pollen immunotherapy inhibits allergen-induced infiltration of CD4+ T lymphocytes and eosinophils in the nasal mucosa and increases the number of cells expressing messenger RNA for interferon-gamma. J Allergy Clin Immunol 1996; 97:1356 - 65; http://dx.doi.org/10.1016/S0091-6749(96)70205-1; PMID: 8648033
   PubMed Web of Science ®Google Scholar
• Razafindratsita A, Saint-Lu N, Mascarell L, Berjont N, Bardon T, Betbeder D, et al. Improvement of sublingual immunotherapy efficacy with a mucoadhesive allergen formulation. J Allergy Clin Immunol 2007; 120:278 - 85; http://dx.doi.org/10.1016/j.jaci.2007.04.009; PMID: 17531296
   PubMed Web of Science ®Google Scholar
• Wachholz PA, Durham SR. Induction of ‘blocking’ IgG antibodies during immunotherapy. Clin Exp Allergy 2003; 33:1171 - 4; http://dx.doi.org/10.1046/j.1365-2222.2003.01765.x; PMID: 12956735
   PubMed Web of Science ®Google Scholar
• Durham SR, Varney VA, Gaga M, Jacobson MR, Varga EM, Frew AJ, et al. Grass pollen immunotherapy decreases the number of mast cells in the skin. Clin Exp Allergy 1999; 29:1490 - 6; http://dx.doi.org/10.1046/j.1365-2222.1999.00678.x; PMID: 10520076
   PubMed Web of Science ®Google Scholar
• Allam JP, Peng WM, Appel T, Wenghoefer M, Niederhagen B, Bieber T, et al. Toll-like receptor 4 ligation enforces tolerogenic properties of oral mucosal Langerhans cells. J Allergy Clin Immunol 2008; 121:368 - 74, e1; http://dx.doi.org/10.1016/j.jaci.2007.09.045; PMID: 18036651
   PubMed Web of Science ®Google Scholar
• Mascarell L, Lombardi V, Louise A, Saint-Lu N, Chabre H, Moussu H, et al. Oral dendritic cells mediate antigen-specific tolerance by stimulating TH1 and regulatory CD4+ T cells. J Allergy Clin Immunol 2008; 122:603 - 9, e5; http://dx.doi.org/10.1016/j.jaci.2008.06.034; PMID: 18774396
   PubMed Web of Science ®Google Scholar
• Zuany-Amorim C, Manlius C, Trifilieff A, Brunet LR, Rook G, Bowen G, et al. Long-term protective and antigen-specific effect of heat-killed Mycobacterium vaccae in a murine model of allergic pulmonary inflammation. J Immunol 2002; 169:1492 - 9; PMID: 12133976
   PubMed Web of Science ®Google Scholar
• Akdis CA, Kussebi F, Pulendran B, Akdis M, Lauener RP, Schmidt-Weber CB, et al. Inhibition of T helper 2-type responses, IgE production and eosinophilia by synthetic lipopeptides. Eur J Immunol 2003; 33:2717 - 26; http://dx.doi.org/10.1002/eji.200323329; PMID: 14515255
   PubMed Web of Science ®Google Scholar
• Trujillo-Vargas CM, Mayer KD, Bickert T, Palmetshofer A, Grunewald S, Ramirez-Pineda JR, et al. Vaccinations with T-helper type 1 directing adjuvants have different suppressive effects on the development of allergen-induced T-helper type 2 responses. Clin Exp Allergy 2005; 35:1003 - 13; http://dx.doi.org/10.1111/j.1365-2222.2005.02287.x; PMID: 16120081
   PubMed Web of Science ®Google Scholar
• Santeliz JV, Van Nest G, Traquina P, Larsen E, Wills-Karp M. Amb a 1-linked CpG oligodeoxynucleotides reverse established airway hyperresponsiveness in a murine model of asthma. J Allergy Clin Immunol 2002; 109:455 - 62; http://dx.doi.org/10.1067/mai.2002.122156; PMID: 11897991
   PubMed Web of Science ®Google Scholar
• Johansen P, Senti G, Martinez Gomez JM, Storni T, von Beust BR, Wüthrich B, et al. Toll-like receptor ligands as adjuvants in allergen-specific immunotherapy. Clin Exp Allergy 2005; 35:1591 - 8; http://dx.doi.org/10.1111/j.1365-2222.2005.02384.x; PMID: 16393325
   PubMed Web of Science ®Google Scholar
• Taher YA, van Esch BC, Hofman GA, Henricks PA, van Oosterhout AJ. 1alpha,25-dihydroxyvitamin D3 potentiates the beneficial effects of allergen immunotherapy in a mouse model of allergic asthma: role for IL-10 and TGF-β. J Immunol 2008; 180:5211 - 21; PMID: 18390702
   PubMed Web of Science ®Google Scholar
• Drachenberg KJ, Wheeler AW, Stuebner P, Horak F. A well-tolerated grass pollen-specific allergy vaccine containing a novel adjuvant, monophosphoryl lipid A, reduces allergic symptoms after only four preseasonal injections. Allergy 2001; 56:498 - 505; http://dx.doi.org/10.1034/j.1398-9995.2001.056006498.x; PMID: 11421893
   PubMed Web of Science ®Google Scholar
• Mothes N, Heinzkill M, Drachenberg KJ, Sperr WR, Krauth MT, Majlesi Y, et al. Allergen-specific immunotherapy with a monophosphoryl lipid A-adjuvanted vaccine: reduced seasonally boosted immunoglobulin E production and inhibition of basophil histamine release by therapy-induced blocking antibodies. Clin Exp Allergy 2003; 33:1198 - 208; http://dx.doi.org/10.1046/j.1365-2222.2003.01699.x; PMID: 12956739
   PubMed Web of Science ®Google Scholar
• Creticos PS, Schroeder JT, Hamilton RG, Balcer-Whaley SL, Khattignavong AP, Lindblad R, et al, Immune Tolerance Network Group. Immunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitis. N Engl J Med 2006; 355:1445 - 55; http://dx.doi.org/10.1056/NEJMoa052916; PMID: 17021320
   PubMed Web of Science ®Google Scholar
• Majak P, Rychlik B, Stelmach I. The effect of oral steroids with and without vitamin D3 on early efficacy of immunotherapy in asthmatic children. Clin Exp Allergy 2009; 39:1830 - 41; http://dx.doi.org/10.1111/j.1365-2222.2009.03357.x; PMID: 19817753
   PubMed Web of Science ®Google Scholar
• Schöll I, Weissenböck A, Förster-Waldl E, Untersmayr E, Walter F, Willheim M, et al. Allergen-loaded biodegradable poly(D,L-lactic-co-glycolic) acid nanoparticles down-regulate an ongoing Th2 response in the BALB/c mouse model. Clin Exp Allergy 2004; 34:315 - 21; http://dx.doi.org/10.1111/j.1365-2222.2004.01884.x; PMID: 14987314
   PubMed Web of Science ®Google Scholar
• Sanders MT, Brown LE, Deliyannis G, Pearse MJ. ISCOM-based vaccines: the second decade. Immunol Cell Biol 2005; 83:119 - 28; http://dx.doi.org/10.1111/j.1440-1711.2005.01319.x; PMID: 15748208
   PubMed Web of Science ®Google Scholar
• Kim N, Kwon SS, Lee J, Kim S, Yoo TJ. Protective effect of the DNA vaccine encoding the major house dust mite allergens on allergic inflammation in the murine model of house dust mite allergy. Clin Mol Allergy 2006; 4:1 - 9; http://dx.doi.org/10.1186/1476-7961-4-4; PMID: 16478539
   PubMedGoogle Scholar
• Terada T. New therapeutic strategies: a chimeric human-cat fusion protein inhibits allergic reactivity. Clin Exp Allergy 2006; 6:96 - 100; http://dx.doi.org/10.1111/j.1365-2222.2006.00108.x
   Google Scholar
• Gerstmayr M, Ilk N, Jahn-Schmid B, Sleytr UB, Bohle B. Natural self-assembly of allergen-S-layer fusion proteins is no prerequisite for reduced allergenicity and T cell stimulatory capacity. Int Arch Allergy Immunol 2009; 149:231 - 8; http://dx.doi.org/10.1159/000199718; PMID: 19218815
   PubMed Web of Science ®Google Scholar
• Schülke S, Burggraf M, Waibler Z, Wangorsch A, Wolfheimer S, Kalinke U, et al. A fusion protein of flagellin and ovalbumin suppresses the TH2 response and prevents murine intestinal allergy. J Allergy Clin Immunol 2011; 128:1340 - 8, e12; http://dx.doi.org/10.1016/j.jaci.2011.07.036; PMID: 21872305
   PubMed Web of Science ®Google Scholar
• Kündig TM, Senti G, Schnetzler G, Wolf C, Prinz Vavricka BM, Fulurija A, et al. Der p 1 peptide on virus-like particles is safe and highly immunogenic in healthy adults. J Allergy Clin Immunol 2006; 117:1470 - 6; http://dx.doi.org/10.1016/j.jaci.2006.01.040; PMID: 16751015
   PubMed Web of Science ®Google Scholar
• Schmitz N, Dietmeier K, Bauer M, Maudrich M, Utzinger S, Muntwiler S, et al. Displaying Fel d1 on virus-like particles prevents reactogenicity despite greatly enhanced immunogenicity: a novel therapy for cat allergy. J Exp Med 2009; 206:1941 - 55; http://dx.doi.org/10.1084/jem.20090199; PMID: 19667059
   PubMed Web of Science ®Google Scholar
• Senti G, Johansen P, Haug S, Bull C, Gottschaller C, Müller P, et al. Use of A-type CpG oligodeoxynucleotides as an adjuvant in allergen-specific immunotherapy in humans: a phase I/IIa clinical trial. Clin Exp Allergy 2009; 39:562 - 70; http://dx.doi.org/10.1111/j.1365-2222.2008.03191.x; PMID: 19226280
   PubMed Web of Science ®Google Scholar
• Edlmayr J, Niespodziana K, Linhart B, Focke-Tejkl M, Westritschnig K, Scheiblhofer S, et al. A combination vaccine for allergy and rhinovirus infections based on rhinovirus-derived surface protein VP1 and a nonallergenic peptide of the major timothy grass pollen allergen Phl p 1. J Immunol 2009; 182:6298 - 306; http://dx.doi.org/10.4049/jimmunol.0713622; PMID: 19414783
   PubMed Web of Science ®Google Scholar
• Crameri R, Kündig TM, Akdis CA. Modular antigen-translocation as a novel vaccine strategy for allergen-specific immunotherapy. Curr Opin Allergy Clin Immunol 2009; 9:568 - 73; http://dx.doi.org/10.1097/ACI.0b013e3283310fdf; PMID: 19680120
   PubMed Web of Science ®Google Scholar
• Freytag LC, Clements JD. Mucosal adjuvants. Vaccine 2005; 23:1804 - 13; http://dx.doi.org/10.1016/j.vaccine.2004.11.010; PMID: 15734046
   PubMed Web of Science ®Google Scholar
• Pizza M, Giuliani MM, Fontana MR, Monaci E, Douce G, Dougan G, et al. Mucosal vaccines: non toxic derivatives of LT and CT as mucosal adjuvants. Vaccine 2001; 19:2534 - 41; http://dx.doi.org/10.1016/S0264-410X(00)00553-3; PMID: 11257389
   PubMed Web of Science ®Google Scholar
• Goldman M. Translational mini-review series on Toll-like receptors: Toll-like receptor ligands as novel pharmaceuticals for allergic disorders. Clin Exp Immunol 2007; 147:208 - 16; http://dx.doi.org/10.1111/j.1365-2249.2006.03296.x; PMID: 17223960
   PubMed Web of Science ®Google Scholar
• Patel M, Xu D, Kewin P, Choo-Kang B, McSharry C, Thomson NC, et al. TLR2 agonist ameliorates established allergic airway inflammation by promoting Th1 response and not via regulatory T cells. J Immunol 2005; 174:7558 - 63; PMID: 15944255
   PubMed Web of Science ®Google Scholar
• Lombardi V, Van Overtvelt L, Horiot S, Moussu H, Chabre H, Louise A, et al. Toll-like receptor 2 agonist Pam3CSK4 enhances the induction of antigen-specific tolerance via the sublingual route. Clin Exp Allergy 2008; 38:1819 - 29; PMID: 18644025
   PubMed Web of Science ®Google Scholar
• Mascarell L, Van Overtvelt L, Lombardi L. Razafindratsita, Moussu H, Horiot S, Chabre H, Paccaud J-P, Limal D, Moutel S, Bauer J, Chiavaroli C, Moingeon P. A synthetic triacylated pseudodipeptide molecule promotes Th1/T Reg immune responses and enhances tolerance induction via the sublingual route. Vaccine 2007; 26:108 - 18; http://dx.doi.org/10.1016/j.vaccine.2007.10.050; PMID: 18063445
   PubMed Web of Science ®Google Scholar
• Van Overtvelt L, Lombardi V, Razafindratsita A, Saint-Lu N, Horiot S, Moussu H, et al. IL-10-inducing adjuvants enhance sublingual immunotherapy efficacy in a murine asthma model. Int Arch Allergy Immunol 2008; 145:152 - 62; http://dx.doi.org/10.1159/000108140; PMID: 17848808
   PubMed Web of Science ®Google Scholar
• de Roock S, van Elk M, van Dijk MEA, Timmerman HM, Rijkers GT, Prakken BJ, et al. Lactic acid bacteria differ in their ability to induce functional regulatory T cells in humans. Clin Exp Allergy 2010; 40:103 - 10; PMID: 19817754
   PubMed Web of Science ®Google Scholar
• Vliagoftis H, Kouranos VD, Betsi GI, Falagas ME. Probiotics for the treatment of allergic rhinitis and asthma: systematic review of randomized controlled trials. Ann Allergy Asthma Immunol 2008; 101:570 - 9; http://dx.doi.org/10.1016/S1081-1206(10)60219-0; PMID: 19119700
   PubMed Web of Science ®Google Scholar
• Van Overtvelt L, Moussu H, Horiot S, Samson S, Lombardi V, Mascarell L, et al. Lactic acid bacteria as adjuvants for sublingual allergy vaccines. Vaccine 2010; 28:2986 - 92; http://dx.doi.org/10.1016/j.vaccine.2010.02.009; PMID: 20175969
   PubMed Web of Science ®Google Scholar
• Moussu H, Van Overtvelt L, Horiot S, Tourdot S, Airouche S, Zuercher A, et al. Bifidobacterium bifidum NCC 453 promotes tolerance induction in murine models of sublingual immunotherapy. Int Arch Allergy Immunol 2012; 158:35 - 42; http://dx.doi.org/10.1159/000330101; PMID: 22205338
   PubMed Web of Science ®Google Scholar
• Pfaar O, Barth C, Jaschke C, Hörmann K, Klimek L. Sublingual allergen-specific immunotherapy adjuvanted with monophosphoryl lipid A: a phase I/IIa study. Int Arch Allergy Immunol 2011; 154:336 - 44; http://dx.doi.org/10.1159/000321826; PMID: 20975285
   PubMed Web of Science ®Google Scholar
• Arikan C, Bahceciler NN, Deniz G, Akdis M, Akkoc T, Akdis CA, et al. Bacillus Calmette-Guérin-induced interleukin-12 did not additionally improve clinical and immunologic parameters in asthmatic children treated with sublingual immunotherapy. Clin Exp Allergy 2004; 34:398 - 405; http://dx.doi.org/10.1111/j.1365-2222.2004.01869.x; PMID: 15005733
   PubMed Web of Science ®Google Scholar
• Kalliomäki M, Salminen S, Poussa T, Arvilommi H, Isolauri E. Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet 2003; 361:1869 - 71; http://dx.doi.org/10.1016/S0140-6736(03)13490-3; PMID: 12788576
   PubMed Web of Science ®Google Scholar
• De Souza Rebouças J, Esparza I, Ferrer M, Sanz ML, Irache JM, Gamazo C. Nanoparticulate adjuvants and delivery systems for allergen immunotherapy. J Biomed Biotechnol 2012; 2012:474605; http://dx.doi.org/10.1155/2012/474605; PMID: 22496608
   PubMed Web of Science ®Google Scholar
• Saint-Lu N, Tourdot S, Razafindratsita A, Mascarell L, Berjont N, Chabre H, et al. Targeting the allergen to oral dendritic cells with mucoadhesive chitosan particles enhances tolerance induction. Allergy 2009; 64:1003 - 13; http://dx.doi.org/10.1111/j.1398-9995.2009.01945.x; PMID: 19220212
   PubMed Web of Science ®Google Scholar
• Jeannin P, Renno T, Goetsch L, Miconnet I, Aubry JP, Delneste Y, et al. OmpA targets dendritic cells, induces their maturation and delivers antigen into the MHC class I presentation pathway. Nat Immunol 2000; 1:502 - 9; http://dx.doi.org/10.1038/82751; PMID: 11101872
   PubMed Web of Science ®Google Scholar
• Goetsch L, Gonzalez A, Plotnicky-Gilquin H, Haeuw JF, Aubry JP, Beck A, et al. Targeting of nasal mucosa-associated antigen-presenting cells in vivo with an outer membrane protein A derived from Klebsiella pneumoniae. Infect Immun 2001; 69:6434 - 44; http://dx.doi.org/10.1128/IAI.69.10.6434-6444.2001; PMID: 11553588
   PubMed Web of Science ®Google Scholar
• Haicheur N, Benchetrit F, Amessou M, Leclerc C, Falguières T, Fayolle C, et al. The B subunit of Shiga toxin coupled to full-size antigenic protein elicits humoral and cell-mediated immune responses associated with a Th1-dominant polarization. Int Immunol 2003; 15:1161 - 71; http://dx.doi.org/10.1093/intimm/dxg118; PMID: 13679386
   PubMed Web of Science ®Google Scholar
• El Azami El Idrissi M, Ladant D, Leclerc C. The adenylate cyclase of Bordetella pertussis: a vector to target antigen presenting cells. Toxicon 2002; 40:1661 - 5; http://dx.doi.org/10.1016/S0041-0101(02)00205-2; PMID: 12457876
   PubMed Web of Science ®Google Scholar
• Mascarell L, Saint-Lu N, Moussu H, Zimmer A, Louise A, Lone Y, et al. Oral macrophage-like cells play a key role in tolerance induction following sublingual immunotherapy of asthmatic mice. Mucosal Immunol 2011; 4:638 - 47; http://dx.doi.org/10.1038/mi.2011.28; PMID: 21775981
   PubMed Web of Science ®Google Scholar
• Hobson P, Barnfield C, Barnes A, Klavinskis LS. Mucosal immunization with DNA vaccines. Methods 2003; 31:217 - 24; http://dx.doi.org/10.1016/S1046-2023(03)00139-7; PMID: 14511954
   PubMed Web of Science ®Google Scholar
• Broos S, Lundberg K, Akagi T, Kadowaki K, Akashi M, Greiff L, et al. Immunomodulatory nanoparticles as adjuvants and allergen-delivery system to human dendritic cells: Implications for specific immunotherapy. Vaccine 2010; 28:5075 - 85; http://dx.doi.org/10.1016/j.vaccine.2010.05.004; PMID: 20478343
   PubMed Web of Science ®Google Scholar
• Hu KF, Lövgren-Bengtsson K, Morein B. Immunostimulating complexes (ISCOMs) for nasal vaccination. Adv Drug Deliv Rev 2001; 51:149 - 59; http://dx.doi.org/10.1016/S0169-409X(01)00165-X; PMID: 11516786
   PubMed Web of Science ®Google Scholar